UnitedHealth Group, winner of APME FX Top 20 Healthcare Companies 2023

Value development

UNH closed the second quarter of 2023 with favorable business results. It thus continued a long-term trend of positive sentiment, which resulted in a price increase. Over the past 5 years, the price per UNH share has increased by 87.42%, and by 334,831% since the stock went public in 1984.*

Snímek obrazovky 2023-07-21 v 20.12.40

United Health Group's share price movement over the past 5 years*

Interestingly, UNH ranks first in BlackRock Investment Group's "iShares" ETFs with a 22.2 percent weighting.  These ETF funds specialize specifically in U.S. health care, health insurance, diagnostics and specialty treatment providers.

Profitability drags

Once again contributing to UNH's solid results were double-digit gains from Optum's divisions, which are used to coordinate patient care, improve the affordability of medical care, analyze cost trends and provide continuity in healthcare delivery.

UnitedHealth Group by the Numbers

UNH is the largest U.S. health insurer, both in terms of market capitalization, revenues or profits, as well as in the number of insureds, which number approximately 70 million. It also works with 1.3 million physicians and around 6,500 hospitals. In addition to the United States, it also operates in Latin America. Founded in 1977, its portfolio includes a number of smaller insurance companies and employs more than 125 thousand people.

----------- 

Peter Svoreň, CEO of APME FX

Sources:

https://www.tradingview.com/news/zacks:03280f47b094b:0-unitedhealth-beats-q2-earnings-updates-view-etfs-to-gain/

https://www.unitedhealthgroup.com/

https://www.nasdaq.com/market-activity/stocks/unh/real-time

https://www.ishares.com/uk/individual/en/products/253713/ishares-dow-jones-industrial-average-ucits-etf

* Past performance is no guarantee of future results

Disclaimer:

The material herein is considered as marketing communication under the relevant laws and regulations, and as such is not a subject to any prohibition on dealing ahead of the dissemination of investment research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and should not be construed as containing investment advice, or an investment recommendation, or an offer of or solicitation for any transactions in financial instruments. The published content is intended for educational/informational purposes only. It does not take into account readers’ financial situation, personal experience or investment objectives. APME FX Trading Europe Ltd makes no representation that the information provided is accurate, current or complete; and therefore, assumes no liability for any losses arising from investments based on the supplied content. The past performance is not a guarantee of future results.

Blog

Strong Airline Results: Will 2025 Be a Better Year for European Air Travel?

The turbulent year of 2024 brought many challenges to European air travel, but the outlook for some carriers suggests potential improvement. Companies like Air France-KLM and Lufthansa anticipate...

Blog

How will tariffs change the current investment landscape?

In recent days, global financial markets have once again come under pressure from growing uncertainty over U.S. trade policy. U.S. President Donald Trump continues his tariff strategy while the Fe...

Blog

German economic engine in trouble. The cause is automotive, which is lagging behind

Germany has the largest economy in Europe and one of the highest living standards in the world. Yet in recent years we hear that Germany is the sick man of Europe and that its economy is losing its brea...

CFDs are complex instruments and carry a high risk of losing money quickly due to leverage, 89.30% of retail investors' accounts are lost when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing money. Please read the Risk Warning.